A recent study has shown that troriluzole can prevent early-stage brain changes in a mouse model of Alzheimer’s disease. The research demonstrated that troriluzole reduces harmful glutamate levels, preserving memory and cognitive function.
You May Also Like
Are Smokers Really Less Likely to Develop Parkinson’s?
September 8, 2024
Tau Levels Predict Memory Loss in Alzheimer’s
September 7, 2024
Upper GI Damage Linked to 76% Higher Parkinson’s Disease Risk
September 7, 2024
More From Author
Complex needs shelter wins praise from Regina police, addiction experts
September 15, 2024
Victoria police chief wants more powers for hospital security
September 14, 2024
+ There are no comments
Add yours